Evidence of RAS-induced lipid metabolic reprograming is well documented through several works demonstrating its role in pancreatic cancer through the control of lipid uptake, storage by the use of LD and through regulation of hormone-sensitive lipase (HSL) [75]. Here, LIPE is linked to pancreatic neoplasm.